Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,274 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Psoas muscle volume as a predictor of peripheral neurotoxicity induced by primary chemotherapy in ovarian cancers.
Yoshikawa T, Takano M, Miyamoto M, Yajima I, Shimizu Y, Aizawa Y, Suguchi Y, Moriiwa M, Aoyama T, Soyama H, Goto T, Hirata J, Suzuki A, Sasa H, Nagaoka I, Tsuda H, Furuya K. Yoshikawa T, et al. Among authors: aoyama t. Cancer Chemother Pharmacol. 2017 Sep;80(3):555-561. doi: 10.1007/s00280-017-3395-5. Epub 2017 Jul 19. Cancer Chemother Pharmacol. 2017. PMID: 28726081
Efficacy of combination chemotherapy using irinotecan and nedaplatin for patients with recurrent and refractory endometrial carcinomas: preliminary analysis and literature review.
Miyamoto M, Takano M, Kuwahara M, Soyama H, Kato K, Matuura H, Sakamoto T, Takasaki K, Aoyama T, Yoshikawa T, Furuya K. Miyamoto M, et al. Among authors: aoyama t. Cancer Chemother Pharmacol. 2018 Jan;81(1):111-117. doi: 10.1007/s00280-017-3454-y. Epub 2017 Nov 9. Cancer Chemother Pharmacol. 2018. PMID: 29124328 Review.
Is there any predictor for hypersensitivity reactions in gynecologic cancer patients treated with paclitaxel-based therapy?
Aoyama T, Takano M, Miyamoto M, Yoshikawa T, Soyama H, Kato K, Ishibashi H, Iwahashi H, Nakatsuka M, Yajima I, Shimizu Y, Aizawa Y, Suguchi Y, Moriiwa M, Goto T, Sasa H, Nagaoka I, Tsuda H, Furuya K. Aoyama T, et al. Cancer Chemother Pharmacol. 2017 Jul;80(1):65-69. doi: 10.1007/s00280-017-3332-7. Epub 2017 May 10. Cancer Chemother Pharmacol. 2017. PMID: 28493032
JAK2/STAT3 pathway as a therapeutic target in ovarian cancers.
Yoshikawa T, Miyamoto M, Aoyama T, Soyama H, Goto T, Hirata J, Suzuki A, Nagaoka I, Tsuda H, Furuya K, Takano M. Yoshikawa T, et al. Among authors: aoyama t. Oncol Lett. 2018 Apr;15(4):5772-5780. doi: 10.3892/ol.2018.8028. Epub 2018 Feb 12. Oncol Lett. 2018. PMID: 29545902 Free PMC article.
2,274 results